Kaori Asamitsu

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico.

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico.

Journal: Biochemistry and biophysics reports
Published: February 03, 2025

Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078.

Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078.

Journal: Molecules (Basel, Switzerland)
Published: November 17, 2022

Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding.

Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding.

Journal: PloS one
Published: August 03, 2022

Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-kB Cascade: In Vitro and In Silico Investigations.

Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-kB Cascade: In Vitro and In Silico Investigations.

Journal: Molecules (Basel, Switzerland)
Published: November 12, 2021

In Vitro Antiviral Activity of Mentha cordifolia Plant Extract in HIV-1 Latently Infected Cells Using an Established Human Cell Line.

In Vitro Antiviral Activity of Mentha cordifolia Plant Extract in HIV-1 Latently Infected Cells Using an Established Human Cell Line.

Journal: AIDS research and human retroviruses
Published: May 25, 2021

Application of fluorescent-based technology detecting protein-protein interactions to monitor the binding of hepatitis B virus X protein to DNA-damage-binding protein 1.

Application of fluorescent-based technology detecting protein-protein interactions to monitor the binding of hepatitis B virus X protein to DNA-damage-binding protein 1.

Journal: Biophysics and physicobiology
Published: August 07, 2020

Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.

Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.

Journal: Blood
Published: August 23, 2019

Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Journal: Oncogene
Published: August 04, 2019

HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies.

HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies.

Journal: Molecules (Basel, Switzerland)
Published: March 30, 2018

Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.

Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.

Journal: Blood
Published: June 20, 2017

The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.

The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.

Journal: Current pharmaceutical design
Published: May 03, 2017

MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding.

MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding.

Journal: PloS one
Published: October 18, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026